Presentation Information
[3P-0552]Combination therapy using clinically approved PPARα/δ/γ subtype-selective agonists in a diet-induced early-stage MASLD mouse model
○akihiro honda1, shotaro kamata1, reina tanaka1, yukiko minomo1, shota ino1, Waka Kamichatani1, Takako Hishiki1, isao ishii1 (1.Showa Pharmaceutical University)
Password required to view
Password required to view or download.
Check your name badge for the password.
Check your name badge for the password.
Comment
To browse or post comments, you must log in.Log in
